Clinical Trial Update: Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL) [Phase 2]

View source ↗

Summary

A Phase 2 prospective, single-arm, single-center clinical trial evaluating duvelisib in combination with chidamide for newly diagnosed peripheral T-cell lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Duvelisib (duvelisib)

Snippet

Sponsor: Liling Zhang | Conditions: Newly Diagnosed Peripheral T-cell Lymphoma | Phase 2 | Status: UNKNOWN